First AD

Second AD

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Precision Medicine in Oncology®

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Special Reports in Personalized Cancer Care

The OncLive Special Reports in Personalized Cancer Care condition center is a comprehensive resource for clinical news and expert insights on personalized  treatment in lung cancer, breast cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, gynecologic cancers, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research as it relates to precision oncology therapeutics. 

Advanced Lung Cancer: A Year in Review 

Peer Exchange

The IMpower150 Regimen

Work-Up and Management of Nondriver Metastatic Lung Cancer

Therapy Approach for PD-L1 Over 50% Lung Cancer

Progression on Immunotherapy: Treatment Approach

PD-L1 Less Than 49%: Available Treatments

Immunotherapy and Brain Metastatic Lung Cancer

How Long to Continue Immunotherapy

When to Use the CheckMate-227 Regimen

Lung Cancer Molecular Testing Protocol

Upfront Targeted Treatment Approach

Oligometastatic and Small Cell Transformation Management

When to Re-Treat with Osimertinib

ALK-Rearranged & MET Exon 14 NSCLC Treatment Options

Brain Metastatic NSCLC: Targeted Therapy Approach

Unresectable Stage III Lung Cancer Management

Stage III NSCLC: When to Start Durvalumab

Stage III NSCLC Progression Treatment Strategy

Small-Cell Lung Cancer: The IMpower133 and CASPIAN trials

Limited-Stage SCLC: Is Immunotherapy an Option?

The Future of Lung Cancer Management